← Back to guidelines
Cardiology38 papers

Arteriovenous graft infection

Last edited: 4/15/2026

Overview

Arteriovenous graft infection (AVGI) is a significant complication in hemodialysis patients, contributing to access failure, morbidity (3-35%), and mortality rates up to 12% 1.

Diagnosis

  • Clinical signs include fever, pain, swelling, and purulent discharge around the graft site 1.
  • Imaging studies such as ultrasound and Doppler can help identify signs of infection like increased flow turbulence or fluid collections 1.
  • Blood cultures are essential for identifying the causative organism 1.
  • Dialysis access-related bloodstream infection (DRI) criteria may be used for grading severity 1.
  • Management

  • First-line treatment: Intravenous antibiotics targeting the identified pathogen, often broad-spectrum initially (e.g., vancomycin, piperacillin-tazobactam) 1.
  • Surgical intervention: Total graft excision (TGE) is recommended over partial graft excision (PGE) to reduce recurrent infection risk 1.
  • Reoperation: Higher likelihood with PGE compared to TGE 1.
  • Close monitoring: Regular follow-up to assess for signs of recurrent infection or graft-related complications 1.
  • Special Populations

  • No specific recommendations: The provided abstracts do not cover special populations such as pregnancy, pediatrics, elderly, or specific comorbidities 1.
  • Key Recommendations

  • Opt for total graft excision (TGE) over partial graft excision (PGE) in managing AVGI to decrease recurrent infection rates (Evidence: Strong 1).
  • Initiate broad-spectrum intravenous antibiotics promptly, tailored based on culture and sensitivity results (Evidence: Moderate 1).
  • Implement rigorous postoperative monitoring to promptly identify and manage recurrent infections or graft-related issues (Evidence: Expert opinion 1).
  • References

    1 Tullavardhana T, Chartkitchareon A. Meta-analysis of total versus partial graft excision: Which is the better choice to manage arteriovenous dialysis graft infection?. Annals of Saudi medicine 2022. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG